Treatment of tumors with vitamin e suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kang, Tae Heung ^a   Knoff, Jayne ^b   Yeh, Wei Hsi ^b   Yang, Benjamin ^b   Wang, Chenguang ^c   Kim, Young Seob ^a   Kim, Tae Woo ^d   Wu, Tzyy Choou ^b   Hung, Chien Fu ^b  

^a Konkuk University   (South Korea)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; NITRIC OXIDE; ALPHA TOCOPHEROL; CD11B ANTIGEN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PROTEIN E7;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE DEFICIENCY; IMMUNOREGULATION; ISOMER; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEOPLASM; NONHUMAN; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TUMOR LOCALIZATION; TUMOR MODEL; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NECROSIS; NEOPLASMS; PATHOLOGY;

ALPHA-TOCOPHEROL; ANIMALS; ANTIGENS, CD11B; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED C57BL; MYELOID CELLS; NECROSIS; NEOPLASMS; NITRIC OXIDE; PAPILLOMAVIRUS E7 PROTEINS;

EID: 84904989729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103562     Document Type: Article

References (28)

1. Constantinou C, Papas A, Constantinou AI (2008) Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 123: 739-752. (Pubitemid 352032398)
2. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, et al. (1986) Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 315: 1250-1254. (Pubitemid 17049683)
3. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, et al. (1993) Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 53: 4230-4237. (Pubitemid 24146771)
4. White E, Shannon JS, Patterson RE (1997) Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 6: 769-774. (Pubitemid 27435473)
5. Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC (2003) Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J Am Coll Nutr 22: 108-117. (Pubitemid 36417824)
6. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, et al. (2002) Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 168: 689-695. (Pubitemid 34049569)
7. Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5: 263-274.
8. Lesokhin AM, Hohl TM, Kitano S, Cortez C, Hirschhorn-Cymerman D, et al. (2012) Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res 72: 876-886.
9. Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12: 269-281.
10. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, et al. (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17: 4550-4557.
11. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, et al. (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114: 535-546.
12. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, et al. (1996) Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 56: 21-26. (Pubitemid 26010379)
13. Wang TL, Ling M, Shih IM, Pham T, Pai SI, et al. (2000) Intramuscular administration of E7-transfected dendritic cells generates the most potent E7- specific anti-tumor immunity. Gene Ther 7: 726-733. (Pubitemid 30255753)
14. Kim D, Hung CF, Wu TC (2007) Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther 18: 575-588. (Pubitemid 47187090)
15. Tseng CW, Hung CF, Alvarez RD, Trimble C, Huh WK, et al. (2008) Pretreatment with cisplatin enhances E7-specific CD8 + T-Cell-mediated antitumor immunity induced by DNA vaccination. Clin Cancer Res 14: 3185-3192.
16. Hahn T, Bradley-Dunlop DJ, Hurley LH, Von-Hoff D, Gately S, et al. (2011) The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer. BMC Cancer 11: 471.
17. Kim TW, Hung CF, Boyd DA, He L, Lin CT, et al. (2004) Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6. Cancer Res 64: 400-405. (Pubitemid 38114124)
18. Burton GW, Traber MG (1990) Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 10: 357-382.
19. Yasunaga T, Kato H, Ohgaki K, Inamoto T, Hikasa Y (1982) Effect of vitamin E as an immunopotentiation agent for mice at optimal dosage and its toxicity at high dosage. J Nutr 112: 1075-1084. (Pubitemid 12021546)
20. Omer B, Akkose A, Kolanci C, Oner P, Ozden I, et al. (1997) Inhibition of mammary carcinogenesis in rats by parenteral high-dose vitamin E. J Natl Cancer Inst89: 972-973. (Pubitemid 27282071)
21. Casaburi I, Puoci F, Chimento A, Sirianni R, Ruggiero C, et al. (2013) Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Mol Nutr Food Res 57: 71-83.
22. Shukla Y, Singh R (2011) Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 1215: 1-8.
23. Jin M, Zhao K, Huang Q, Shang P (2013) Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int J Biol Macromol.
24. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, et al. (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108: 669-678. (Pubitemid 32906195)
25. Kim TW, Hung CF, Zheng M, Boyd DA, He L, et al. (2004) A DNA vaccine coexpressing antigen and an anti-apoptotic molecule further enhances the antigenspecific CD8+ T-cell immune response. J Biomed Sci 11: 493-499. (Pubitemid 38721033)
26. Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, et al. (2009) A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res 15: 361-367.
27. Malmberg KJ, Lenkei R, Petersson M, Ohlum T, Ichihara F, et al. (2002) A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer. Clin Cancer Res 8: 1772-1778. (Pubitemid 34633734)
28. Yang CS, Suh N, Kong AN (2012) Does vitamin E prevent or promote cancer? Cancer Prev Res (Phila) 5: 701-705.